Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico, Accurate and Sensitive UHPLC–Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma, «PHARMACEUTICS», 2026, 18, Article number: 377, pp. 1 - 15 [articolo]Open Access
Gatti, Milo; Bonazzetti, Cecilia; Secci, Benedetta; Giorgi, Beatrice; Rinaldi, Matteo; Cojutti, Pier Giorgio; Ambretti, Simone; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico, Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2026, 10.1016/j.ijantimicag.2026.107811, pp. 1 - 10 [articolo]
Gatti, Milo; De Paola, Riccardo; Rinaldi, Matteo; Laici, Cristiana; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non‐Attainment of CI Beta‐Lactam Therapy for Posttransplant Gram‐Negative Infections, «TRANSPLANT INFECTIOUS DISEASE», 2026, 10.1111/tid.70237, pp. 1 - 9 [articolo]
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Ambretti, Simone; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2026, 81, Article number: dkag009, pp. 1 - 5 [articolo]Open Access
Gatti, Milo; De Paola, Riccardo; Giorgi, Beatrice; Pea, Federico, Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR
Pseudomonas aeruginosa
infections: a systematic review and meta-analysis, «CLINICAL INFECTIOUS DISEASES», 2026, 10.1093/cid/ciag194, pp. 1 - 23 [articolo]
Gatti, Milo; Pea, Federico, Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directions, «EXPERT OPINION ON PHARMACOTHERAPY», 2026, 10.1080/14656566.2026.2651279, pp. 1 - 19 [articolo]
Gatti, Milo; Pea, Federico, Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?, «INFECTIOUS DISEASE REPORTS», 2026, 18, Article number: 3, pp. 1 - 4 [articolo]Open Access
Gatti, Milo; Pea, Federico, Re: ‘Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis’ by Chiriac et al, «CLINICAL MICROBIOLOGY AND INFECTION», 2026, 10.1016/j.cmi.2026.05.006, pp. 1 - 2 [replica/breve intervento]
Gatti, Milo; Pea, Federico, Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations, «INFECTION AND DRUG RESISTANCE», 2026, 19, pp. 1 - 23 [articolo]Open Access
Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico, Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion, «PHARMACEUTICS», 2026, 18, Article number: 91, pp. 1 - 20 [articolo]Open Access
Di Bella, Stefano; Geremia, Nicholas; Pea, Federico; Zeitlinger, Markus; Sanson, Gianfranco; Monticelli, Jacopo; Bergmann, Felix; Motet, Christian; Lambotte-Buffet, Christophe; Zerbato, Verena; Gatti, Milo, When and How to Use Subcutaneous Antibiotics, «CLINICAL INFECTIOUS DISEASES», 2026, 10.1093/cid/ciaf691, pp. 1 - 12 [articolo]
Gatti, Milo; Rinaldi, Matteo; Cojutti, Pier Giorgio; Bonazzetti, Cecilia; Siniscalchi, Antonio; Tonetti, Tommaso; Ambretti, Simone; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, 69, pp. 1 - 12 [articolo]Open Access
Gatti, M.; Rinaldi, M.; Bonazzetti, C.; Siniscalchi, A.; Tonetti, T.; Ambretti, S.; Giannella, M.; Viale, P.; Pea, F., A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar?, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 1543 - 1551 [articolo]Open Access
Bonazzetti, Cecilia; Rocchi, Ettore; Toschi, Alice; Derus, Nicolas Riccardo; Sala, Claudia; Pascale, Renato; Rinaldi, Matteo; Campoli, Caterina; Pasquini, Zeno Adrien Igor; Tazza, Beatrice; Amicucci, Armando; Gatti, Milo; Ambretti, Simone; Viale, Pierluigi; Castellani, Gastone; Giannella, Maddalena, Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections, «NPJ DIGITAL MEDICINE», 2025, 8, Article number: 319, pp. 1 - 6 [articolo]Open Access
Rinaldi, M.; Gatti, M.; Giannella, M., Avoiding resistance development to newer drugs: open research lines, «CLINICAL MICROBIOLOGY AND INFECTION», 2025, 32, pp. 543 - 553 [articolo]Open Access
